Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07109739 · ClinicalTrials.gov registry record · NA
Dose-Response Effects of Inspiratory Muscle Strength Training on Blood Pressure and Vascular Function
A NA study of Systolic Hypertension and Brachial Artery Flow-mediated Dilation, sponsored by University of Minnesota.
- Recruiting
- Registry status
- NA
- Development phase
- 144
- Enrollment target
- 1
- Study location
NCT07109739: Recruiting NA study of Systolic Hypertension and Brachial Artery Flow-mediated Dilation, sponsored by University of Minnesota.
NCT07109739 is a NA study of Systolic Hypertension and Brachial Artery Flow-mediated Dilation that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 144 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07109739, a NA study of Systolic Hypertension and Brachial Artery Flow-mediated Dilation, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- NA
- Development phase
- 144 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will assess the dose-response effects of Inspiratory Muscle Strength Training (IMST) in adults with above-normal systolic blood pressure over a 6-week period.
Primary Outcome
To determine resting SBP before and after 6 weeks of IMST 15, IMST 30, or IMST 45 (75% PI max for all groups) in men and women aged ≥18 years with resting SBP ≥120 mmHg.
Conditions Studied
Interventions
- DEVICE POWERbreathe K5
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2025-10-24 |
| Est. Completion | 2027-03-31 |
| Phase | NA |
What NCT07109739 shows while recruiting
NCT07109739 is an interventional study that assigns participants to a tested intervention. The registered 144 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 2 conditions, with Systolic Hypertension appearing as the primary indexed condition, and to 1 intervention - of which POWERbreathe K5 is the first listed.
NCT07109739 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT07109739 about?
NCT07109739 is a clinical study titled "Dose-Response Effects of Inspiratory Muscle Strength Training on Blood Pressure and Vascular Function". This study will assess the dose-response effects of Inspiratory Muscle Strength Training (IMST) in adults with above-normal systolic blood pressure over a 6-week period.
What is the current status of trial NCT07109739?
This trial is currently recruiting. It is a NA study. The enrollment target is 144 participants. The study started on 2025-10-24. Estimated completion is 2027-03-31.
What conditions does trial NCT07109739 study?
This clinical trial studies the following conditions: Systolic Hypertension, Brachial Artery Flow-mediated Dilation.
What interventions are being tested in trial NCT07109739?
The interventions under investigation include: POWERbreathe K5 (DEVICE).
Who is sponsoring clinical trial NCT07109739?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07109739 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Systolic Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07109739's enrollment target sits among peer trials
144 706th of 2000 higher than 1,290 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01861106 · 144 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
- NCT03482245 · 144 participants · NA
The Role of Circadian Clock Proteins in Innate and Adaptive Immunity
- NCT03504683 · 144 participants · NA
MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes
- NCT03905603 · 144 participants · Early Phase 1
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI